Corinne Van Hoven, a senior honors medical diagnostics major, spent the summer conducting cancer research at Fox Chase Cancer ...
Backed by New Medical Association Certification, Insumate® Becomes the Only Bitter Melon Peptide Globally Recognized by ...
Zacks Investment Research on MSN
Will strength in biotechnology unit continue to drive Danaher's growth?
Danaher Corporation DHR has been benefiting from strength in its Biotechnology segment. In the third quarter of 2025, the ...
The agency’s budget has grown steadily since the 1960s, fueling an industry that creates lifesaving medicines and attracts ...
Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement ...
LOS ANGELES, CA – The University of California, Los Angeles, has received a bequest of more than $4 million that will permanently strengthen the training of future physician scientists, marking one of ...
In a written response to a question in the Rajya Sabha, Minister of State for Health and Family Welfare Prataprao Jadhav said ...
Completion of Enrollment Positions CELZ for Near-Term Data Catalysts and Accelerates Path Toward Commercialization of a Transformative, Non-Opioid Therapy for Chronic Lower Back Pain ...
Explore the challenges and opportunities in enhancing India's medical research ecosystem to unlock its potential for ...
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a ...
Innovation cycles are shifting at a remarkable pace. Artificial intelligence, biotechnology and clean energy systems now influence how nations design public pol ...
Seventy-three pharmaceutical, biotechnology and medical device companies from mainland China filed for IPOs in Hong Kong this year, a review by BioWorld found. In the second half of 2025, 43 new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results